HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis (2010)
Fonte: Vaccine. Unidades: FMRP, FCFRP
Assuntos: PARACOCCIDIOIDES (TRATAMENTO), IMUNOTERAPIA
ABNT
RIBEIRO, Alice M. et al. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis. Vaccine, v. 28, n. 6, p. 1528-1534, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.11.062. Acesso em: 08 nov. 2024.APA
Ribeiro, A. M., Bocca, A. L., Amaral, A. C., Souza, A. C. C. O., Faccioli, L. H., Coelho-Castelo, A. A. M., et al. (2010). HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis. Vaccine, 28( 6), 1528-1534. doi:10.1016/j.vaccine.2009.11.062NLM
Ribeiro AM, Bocca AL, Amaral AC, Souza ACCO, Faccioli LH, Coelho-Castelo AAM, Figueiredo F, Silva CL, Felipe MSS. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis [Internet]. Vaccine. 2010 ; 28( 6): 1528-1534.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.vaccine.2009.11.062Vancouver
Ribeiro AM, Bocca AL, Amaral AC, Souza ACCO, Faccioli LH, Coelho-Castelo AAM, Figueiredo F, Silva CL, Felipe MSS. HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis [Internet]. Vaccine. 2010 ; 28( 6): 1528-1534.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.vaccine.2009.11.062